Jaime W. Vieser - 03 Jul 2025 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Director
Signature
/s/ Melinda Lackey
Issuer symbol
TCRT
Transactions as of
03 Jul 2025
Net transactions value
$0
Form type
4
Filing time
07 Jul 2025, 19:11:11 UTC
Previous filing
26 Jun 2025
Next filing
26 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Vieser Jaime Director C/O ALAUNOS THERAPEUTICS, INC., 2617 BISSONNET ST, SUITE 233, HOUSTON /s/ Melinda Lackey 07 Jul 2025 0001846045

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRT Common Stock Award $0 +3,400 +19% $0.000000 21,159 03 Jul 2025 Direct F1
holding TCRT Common Stock 2,100 03 Jul 2025 by Reporter's children
holding TCRT Common Stock 13,503 03 Jul 2025 By Brushwood LLC F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (right to buy) Award $0 +6,400 $0.000000 6,400 03 Jul 2025 Common Stock 6,400 $5.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units (RSUs) which immediately vested upon grant. After the reported acquisition of the RSUs, the reporting person owned in aggregate 21,159 shares of common stock (17,759 previously owned shares, plus the instant grant of 3,400 RSUs).
F2 The shares are directly held by Brushwood LLC. The Reporting Person is the Manager of Brushwood LLC.
F3 One-twelfth of the Option vests each month on the monthly anniversary of July 3, 2025, with any amount that remains unvested on the date immediately preceding the Company's 2026 annual general meeting of stockholders vesting thereon.